報價延遲最少15分鐘:2025/01/11 11:11 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.02 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.11/-1.41
|
|
企業價值
40.45M
|
| 資產負債 |
|
每股賬面淨值
0.67
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/11 11:11 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies. |